[1] Keshavarz Alikhani H, Zargan J, Bidmeshkipour A, Haji Nour
Mohammadi A, Hosseinpour M, Heydari A, et al. Antibacterial
activity of the Iranian scorpion’s crude venom (Odontobuthus
bidentatus) on gram-positive and gram-negative bacteria. Iranian
J Toxicol. 2020; 14(2):105-10. [DOI:10.32598/ijt.14.2.627]
[2] Zargan J, Mirzaei Nodushan M, Sobati H, Goodarzi H, Haji
Noor Mohammadi A, Ebrahimi F. [Anti-cancer and anti-bacterial
effects of crude venom of Pseudocerastes persicus snake
(Persian)]. Koomesh. 2020; 22(3):518-28. [DOI:10.29252/koomesh.
22.3.518]
[3] de Lima DC, Alvarez Abreu P, de Freitas CC, Santos DO, Borges
RO, Dos Santos TC, et al. Snake Venom: Any clue for antibiotics
and CAM? Evid Based Complement Alternat Med. 2005;
2(1):39-47 [DOI:10.1093/ecam/neh063] [PMID] [PMCID]
[4] Ferreira S. A bradykinin-potentiating factor (BPF) present
in the venom of Bothrops jararaca. Br J Pharmacol Chemother.
1965; 24(1):163-9. [DOI:10.1111/j.1476-5381.1965.
tb02091.x] [PMID] [PMCID]
[5] Aloof-Hirsch S, de Vries A, Berger A. The direct lytic factor of
cobra venom: Purification and chemical characterization. Biochim
Biophys Acta. 1968; 154(1):53-60. [DOI:10.1016/0005-
2795(68)90257-2] [PMID]
[6] Xie JP, Yue J, Xiong YL, Wang WY, Yu SQ, Wang HH. In vitro
activities of small peptides from snake venom against clinical
isolates of drugresistant Mycobacterium tuberculosis. Int J
Antimicrob Agents. 2003; 22(2):172-4. [DOI:10.1016/S0924-
8579(03)00110-9] [PMID]
[7] Markland FS. Snake venoms. Drugs. 1997; 54(S3):1-10.
[DOI:10.2165/00003495-199700543-00003] [PMID]
[8] Stábeli RG, Marcussi S, Carlos GB, Pietro RC, Selistre-de-Araújo
HS, Giglio JR, et al. Platelet aggregation and antibacterial effects
of an L-amino acid oxidase purified from Bothrops alternatus
snake venom. Bioorg Med Chem. 2004; 12(11):2881-6.
[DOI:10.1016/j.bmc.2004.03.049] [PMID]
[9] Lu QM, Wei Q, Jin Y, Wei JF, Wang WY, Xiong YL. L-Amino acid
oxidase from Trimeresurus jerdonii snake venom: purification,
characterization, platelet aggregation-inducing and antibacterial
effects. J Nat Toxins. 2002; 11(4):345-52. [PMID]
[10] Chellapandi P, Jebakumar SRD. Purification and antibacterial
activity of indian cobra and viper venoms. Electronic Journal of
Biology. 2008; 4(1):11-6. [Link]
[11] Steuten J, Winkel K, Carroll T, Williamson NA, Ignjatovic V,
Fung K, et al. The molecular basis of cross-reactivity in the
Australian Snake Venom Detection Kit (SVDK). Toxicon. 2007;
50(8):1041-52. [DOI:10.1016/j.toxicon.2007.07.023] [PMID]
[12] Wang H, Cheng H, Wang F, Wei D, Wang X. An improved
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) reduction assay for evaluating the viability of Escherichia
coli cells. J Microbiol Methods. 2010; 82(3):330-3.
[DOI:10.1016/j.mimet.2010.06.014] [PMID]
[13] Hossein Pour M, Zargan J, Honari H, Haji Nour Mohammadi
A, Hajizadeh A, Keshavarz Alikhani H, et al. Introduction of Dianthins:
A new promising horizon toward continuous research
Zargan J, et al. Evalution of Antibacterial and Anticancer of Pseudocerastes Persicus Venom Proteins. JSMJ. 2022; 21(1):122-137
137
Apr, May 2022. Volume 21. Number 1
sicus fieldi and evaluation of their antiplatelet activity. Iran J
Pharm Res. 2012; 11(4):1183-9. [PMID] [PMCID]
[26] Bhaskar M, Monica K, Amod K. Determination of molecular
mass and partial peptide confirmation of short neurotoxins
using chromatographic techniques and reverse phase HPLC.
Int J Appl Biol Pharm Technol. 2011; 2(4):150-7. [Link]
[27] Barker RA, Ratcliffe E, McLaughlin M, Richards A, Dunnett
SB. A role for complement in the rejection of porcine ventral
mesencephalic xenografts in a rat model of Parkinson’s disease.
J Neurosci. 2000; 20(9):3415-24. [DOI:10.1523/JNEUROSCI.
20-09-03415.2000] [PMID] [PMCID]
[28] Zhao X, Yeh JZ, Narahashi T. Post-stroke dementia:
Nootropic drug modulation of neuronal nicotinic acetylcholine
receptors. Annu N Y Acad Sci. 2001; 939(1):179-86.
[DOI:10.1111/j.1749-6632.2001.tb03624.x] [PMID]
[29] Marcinkiewicz C, Weinreb PH, Calvete JJ, Kisiel DG, Mousa
SA, Tuszynski GP, et al. Obtustatin: A potent selective inhibitor
of α1β1 integrin in vitro and angiogenesis in vivo. Cancer Res.
2003; 63(9):2020-3. [PMID]
[30] Li S, Wang J, Zhang X, Ren Y, Wang N, Zhao K, et al. Proteomic
characterization of two snake venoms: Naja naja atra
and Agkistrodon halys. Biochem J. 2004; 384(1):119-27.
[DOI:10.1042/BJ20040354] [PMID] [PMCID]
[31] Angulo Y, Lomonte B. Inhibitory effect of fucoidan on the
activities of crotaline snake venom myotoxic phospholipases
A2. Biochem Pharmacol. 2003; 66:1993-2000. [DOI:10.1016/
S0006-2952(03)00579-3]
Zargan
)